Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Response to medical treatment in patients with Crohn's disease: the role of NOD2/CRAD15, disease phenotype, and age of diagnosis.

Digestive diseases and sciences - 1 Jun 2010

Weiss B, Lebowitz O, Fidder H H, Maza I, Levine A, Shaoul R, Reif S, Bujanover Y, Karban A

Abstract excerpt

PURPOSE: Factors influencing response to medications in Crohn's disease (CD) patients are not fully understood. We aimed to evaluate the relationships between NOD2/CARD15 mutations, disease phenotype and age of CD diagnosis and response to medical treatment with systemic steroids, azathioprine (AZA) or 6-mercaptopurine (6-MP), and infliximab. METHODS: A retrospective medical records analysis was made of patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Azathioprine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gastrointestinal Agents

Share to Infliximab

Share to Israel

Share to Mercaptopurine

Share to Nod2 Signaling Adaptor Protein

Share to Steroids

Source

Identifiers

PMID: 19693669
DOI: 10.1007/s10620-009-0936-8

Genes

NOD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Response to medical treatment in patients with Crohn's disease: the role of NOD2/CRAD15, disease phenotype, and age of diagnosis.PMID 19693669Read ↗

NOD2/CARD15 mutations in Croatian patients with Crohn's disease: prevalence and genotype-phenotype relationship.Semantic proximity Read ↗

Disease duration and age influence CARD15 expression in Crohn's disease.Semantic proximity Read ↗

Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease.Semantic proximity Read ↗

Long-Term Follow-Up, Association between CARD15/NOD2 Polymorphisms, and Clinical Disease Behavior in Crohn's Disease Surgical Patients.Semantic proximity Read ↗

The role of the NOD2/CARD15 gene in surgical treatment prediction in patients with Crohn's disease.Semantic proximity Read ↗

NOD2/CARD15 does not influence response to infliximab in Crohn's disease.Semantic proximity Read ↗

Pediatric onset Crohn's colitis is characterized by genotype-dependent age-related susceptibility.Semantic proximity Read ↗

Disease behavior in children with Crohn's disease: the effect of disease duration, ethnicity, genotype, and phenotype.Semantic proximity Read ↗

NOD2/CARD15 gene influences disease behaviour but not IBD susceptibility in a Moroccan population.Semantic proximity Read ↗

Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.Semantic proximity Read ↗

Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes.Semantic proximity Read ↗

Association of NOD2/CARD15 mutations with previous surgical procedures in Crohn's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.